alexa Theranostic Nanoparticles: A Recent Breakthrough in Nanotechnology | Open Access Journals
ISSN: 2157-7439
Journal of Nanomedicine & Nanotechnology
Like us on:
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Theranostic Nanoparticles: A Recent Breakthrough in Nanotechnology

Narayan Bhattarai1* and Shanta R. Bhattarai2

1Department of Chemical, Biological and Bioengineering, North Carolina A&T State University, Greensboro, NC, USA

2Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

*Corresponding Author:
Narayan Bhattarai
Department of Chemical
Biological and Bioengineering
North Carolina A & T State University
McNair 326, Greensboro, NC, USA
E-mail: [email protected]

Received Date: August 24, 2012; Accepted Date: August 24, 2012; Published Date: August 26, 2012

Citation: Bhattarai N, Bhattarai SR (2012) Theranostic Nanoparticles: A Recent Breakthrough in Nanotechnology. J Nanomed Nanotechol 3:e114. doi:10.4172/2157-7439.1000e114

Copyright: © 2012 Bhattarai N, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Nanomedicine & Nanotechnology

As a revolutionary new 21st century technology, nanotechnology is starting to impact almost every aspect of society. Disease diagnosis and treatment is one of the highest impact areas where nanotechnology has excellent potential and promise [1,2]. Nanotechnology is also aiding in the formation of molecular systems that designed to be noticeably similar to living systems, which could be the basis for the regeneration of body parts that are currently lost due to infection, accident, or disease [3]. The National Cancer Institute, for instance, has created the Alliance for Nanotechnology in Cancer in the hope that investments in biomedical nanotechnology, such as nanomedicine, will lead to breakthroughs in terms of detecting, diagnosing, and treating various forms of cancer. Nanotechnology is already moving from being used as a passive structure in applications such as in cosmetics and sunscreens to active structures in clinical applications such as pharmaceuticals (targetable “smart drugs”). In the present context, nanotechnology is almost paronymous with nanoparticles, an umbrella term that refers to particles at dimensions of roughly about 100 nm or less. Integration of therapeutic compounds into nanoparticles with diagnostic agents refers to the theranostic nanoparticles (imaging and therapy). Examples of such nanotechnology products approved by the Food and Drug Administration (FDA) for human applications are based on iron oxide, gold, protein, liposomes and synthetic polymers [4,5].

In contract to traditional macroscopic materials, nanomaterials have high ratio of surface area to volume as well as tunable optical, electronic, magnetic, and biologic properties, they can be engineered to have different sizes, shapes, chemical compositions, and surface chemical characteristics [4,5]. The field of “theranostic nanoparticles” aims to use these properties and physical characteristics of nanomaterials for the diagnosis and treatment of diseases at the molecular level. For example, in cancer nanotheranostics, nanoparticles are functionalized by combining imaging and therapeutic agents to interact with cancer cells at the molecular level in such a way that the functionalized combo particles can significantly improve the effectiveness and specificity of therapy to cancers that are currently difficult to treat.

Surface functionalization of theranostic nanoparticles is one of the serious technological hurdles specially to maintain their dispersity, biocompatibility and biostability in physiological condition. Nanoparticles have high surface energy and tend to agglomerate and adsorb plasma proteins in body. Agglomerated nanoparticles are easily recognized by body’s immune system and can be very toxic to body tissues. Therefore, a robust surface functionalization method is most important steps to increase particle dispersity and colloidal stability. Creating a water soluble polymer based non-fouling surface on the nanoparticles surface has been found as one of the most successful techniques to prevent the particle agglomeration, prolong the particle circulation time in the blood, and enhance the particle penetration across the biological barriers such as blood brain barriers [6]. The polymer shell also provides active sites for the conjugation of targeting ligands and diagnostic fluorophores offering nanoparticles specificity to diseased cells and an optical imaging visualization, respectively.

In addition, there is growing speculation about possible nanomaterial toxicity on the basis of in vitro cell-culture studies and in vivo animal studies. To translate these applications into clinical use, researchers must optimize the nanomaterials, beginning with small-animal models and scaling up to nonhuman primate models — a process that requires relatively long time. These studies should provide a solid foundation for the long-term advancement of the theranostic nanoparticles into an effective new area in clinical medical practice. In order to fully realize such promises of nanotechnology in medicine, sharing the successes and challenges as well as disseminating the research findings in broader audience focused peer-reviewed journals, conferences and workshops are also equally important.

Acknowledgements

Authors would like to acknowledge Engineering Research Center for Revolutionizing Metallic Biomaterials (ERC-RMB) and Nanotechnology Undergraduate Education (NUE) form NSF for funding support.

References

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Recommended Conferences

Article Usage

  • Total views: 11608
  • [From(publication date):
    August-2012 - Oct 22, 2017]
  • Breakdown by view type
  • HTML page views : 7839
  • PDF downloads :3769
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

materials[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords